Comparison of dissolution profiles obtained from nifedipine extended release once a day products using different dissolution test apparatuses

European Journal of Pharmaceutical Sciences

Volumn 38, Issue 2, 2009, Pages 147-155

  Garbacz, Grzegorz ^a   Golke, Berit ^a,b   Wedemeyer, Ralph Steven ^a   Axell, Marie ^b   Söderlind, Erik ^b   Abrahamsson, Bertil ^b   Weitschies, Werner ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Bio relevant dissolution test; Dissolution stress test; Hydrogel matrix tablets; Nifedipine extended release; OROS; Rotating beaker apparatus

Indexed keywords

GITS ADALAT OROS; NIFEDIPIN SANDOZ RETARD; NIFEDIPINA CORAL; NIFEDIPINE; UNCLASSIFIED DRUG;

ARTICLE; BIOEQUIVALENCE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG SOLUBILITY; DRUG STABILITY; HYDROGEL; PH; PHYSICAL CHEMISTRY; PREDICTION; PRIORITY JOURNAL; TABLET DISINTEGRATION; TABLET FORMULATION;

CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; NIFEDIPINE; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 68949190912     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2009.06.010     Document Type: Article

References (36)

1. Abrahamsson B., Alpsten M., Bake B., Jonsson U.E., Lepkowska M.E., and Larsson A. Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J. Control. Release 52 (1998) 301-310
2. Abrahamsson B., Anupam P., Sjöberg M., Carlsson M., Laurell E., and Brasseur J.G. A novel in vitro and numerical analysis of shear-induced drug release from extended-release tablets in the fed stomach. Pharm. Res. 22 (2005) 1215-1226
3. Aoki S., Ando H., Tatsuishi K., Uesugi K., and Ozawa H. Determination of the mechanical impact force in the in vitro dissolution test and evaluation of the correlation between in vivo and in vitro release. Int. J. Pharm. 95 (1993) 67-75
4. Baxter J.L., Kukura J., and Muzzio F.J. Shear-induced variability in the United States pharmacopeia apparatus 2: modifications to the existing system. AAPS J. 7 (2006) E857-E864
5. Becket A.H., Quach T.T., and Kurs G.S. Improved hydrodynamics for USP apparatus 2. Dissol. Technol. (1996) 7-12
6. Cassilly D., Kantor S., Knight L.C., Maurer A.H., Fisher R.S., Semler J., and Parkman H.P. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol. Motil. 20 (2008) 311-319
7. Colombo P., Bettini R., Massimo G., Catellani P.L., Santi P., and Peppas N.A. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J. Pham. Sci. 84 (1995) 991-997
8. Davis S.S., Hardy J.G., and Fara J.W. Transit of pharmaceutical dosage forms through the small intestine. Gut 27 (1986) 886-892
9. Dürig T., Lusvardi K., and Harcum W.W. HPMC in modified release matrix systems. Hercules pharmaceutical technology report. PTR (2004) 029
10. Ewe K., Press A.G., Bollen S., and Schuhn I. Gastric emptying of indigestible tablets in relation to composition and time of ingestion of meals studied by metal detector. Dig. Dis. Sci. 36 (1991) 146-152
11. Garbacz G., Wedemeyer R.S., Nagel S., Giessmann T., Mönnikes H., Wilson C.G., Siegmund W., and Weitschies W. Irregular absorption profiles observed from diclofenac extended release tabletscan be predicted using a dissolution test apparatus that mimics in vivo physical stresses. Eur. J. Pharm. Biopharm. 70 (2008) 421-428
12. Grundy J.S., and Foster R.T. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin. Pharmacokin. 30 (1996) 28-51
13. Grundy J.S., Anderson K.E., Rogers J.A., and Foster R.T. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro dissolution test. J. Control. Release 48 (1997) 1-8
14. Jantratid E., Janssen N., Reppas C., and Dressman J.B. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm. Res. 25 (2008) 1663-1676
15. Kalantzi L., Goumas K., Kalioras V., Abrahamsson B., Dressman J.B., and Reppas C. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm. Res. 23 (2006) 165-176
16. Kamba M., Seta Y., Kusai A., Ikeda M., and Nishimura K. A unique dosage form to evaluate the mechanical destructive force in the gastrointestinal tract. Int. J. Pharm. 208 (2000) 61-70
17. Karim A., Burns T., Janky D., and Hurwitz A. Food-induced changes in theophylline absorption from controlled-release formulations. Part II. Importance of meal composition and dosing time relative to meal intake in assessing changes in absorption. Clin. Pharmacol. Ther. 38 (1985) 642-647
18. Kavanagh N., and Corrigan O.I. Swelling and erosion properties of hydroxypropylmethylcellulose (hypromellose) matrices-influence of agitation rate and dissolution medium composition. Int. J. Pharm. 279 (2004) 141-152
19. Khamanga S.M., and Walker R.B. The effects of buffer molarity, agitation rate, and mesh size on verapamil release from modified-release mini-tablets using USP apparatus 3. Dissol. Technol. 14 (2007) 19-23
20. McCarthy G.L., Kosiol C., Healy A.M., Bradley G., Sexton J.C., and Corrigan O.I. Simulating the hydrodynamic conditions in the United States pharmacopeia paddle dissolution apparatus. AAPS Pharm. Sci. Tech. 4 (2003) e22
21. McCarthy G.L., Bradley G., Sexton J.C., Corrigan O.I., and Healy A.M. Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns, and fluid velocities. AAPS Pharm. Sci. Tech. 5 (2004) e31
22. Missaghi S., and Fassihi R. Release characterization of dimenhydrinate from an eroding and swelling matrix: selection of appropriate dissolution apparatus. Int. J. Pharm. 293 (2005) 35-42
23. Pillay V., and Fassihi R. Evaluation and comparison of dissolution data derived from different modified release dosage forms: an alternative method. J. Control. Release 55 (1998) 45-55
24. Qureshi S.A. A new crescent-shaped spindle for drug dissolution testing-but why a new spindle?. Dissol. Technol. 11 (2004) 13-18
25. Russell T.L., Berardi R.R., Barnett J.L., Dermentzoglou L.C., Jarvenpaa K.M., Schmaltz S.P., and Dressman J.B. Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm. Res. 10 (1993) 187-196
26. Schiller C., Frohlich C.P., Giessman T., Siegmund W., Monnikes H., Hostein N., and Weitschies W. Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment. Pharmacol. Ther. 22 (2005) 971-979
27. Schug B., Brendel E., Wolf D., Wonnemann M., Wargenau M., and Blume H.H. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union. Eur. J. Pharm. Sci. 15 (2002) 279-285
28. Schug B., Brendel E., Chantraine E., Wolf D., Martin W., Schall R., and Blume H.H. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast. Br. J. Clin. Pharm. 53 (2002) 582-588
29. Schwartz A., Matlib M.A., Balwierczak J., and Lathrop D.A. Pharmacology of calcium antagonists. Am. J. Cardiol. 55 (1985) 3C-7C
30. Soons P.A., Schoemaker H.C., Cohen A.F., and Breimer D.D. Intraindividual variability in nifedipine pharmacokinetics and effects in healthy subjects. Clin. Pharmacol. 32 (1992) 324
31. Tahara K., Yamamoto K., and Nishihata T. Application of model-independent and model analysis for the investigation of effect of drug solubility on its release rate from hydroxypropyl methylcellulose sustained release tablets. Int. J. Pharm. 133 (1996) 17-28
32. Total C.B. Formulation dependent pharmacokinetics-does the dosage form matter for nifedipine?. J. Cardiovasc. Pharmacol. 44 (2004) 82-86
33. US Pharmacopoeia, USP XXVIII (2005), U.S. Pharmacopoeial Convention, Inc., Rockville, MD pp. 808-810
34. Walley T.J., Heagerty A.M., Woods K.L., Bing R.F., Pohl J.E., and Barnett D.B. Pharmacokinetics and pharmacodynamics of nifedipine infusion in normal volunteers. Br. J. Clin. Pharmacol. 23 (1987) 693-701
35. Weitschies W., Kosch O., Mönnikes H., and Trahms L. Magnetic marker monitoring: an application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms. Adv. Drug Deliv. Rev. 57 (2005) 1210-1222
36. Wonnemann M., Schug B., Anschütz M., Brendel E., Nucci G.D., and Blume H.H. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study. Clin. Ther. 30 (2008) 48-58